ACCOLATE (Par Pharmaceutical Inc.)
Welcome to the PulseAid listing for the ACCOLATE drug offered from Par Pharmaceutical Inc.. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical Inc. |
| NON-PROPRIETARY NAME: | zafirlukast |
| SUBSTANCE NAME: | ZAFIRLUKAST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-01-09 |
| END MARKETING DATE: | 0000-00-00 |
ACCOLATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ACCOLATE from Par Pharmaceutical Inc. |
| LABELER NAME: | Par Pharmaceutical Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2015-01-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49884-010_47ad879f-77c0-4955-a5a1-783aaa19d59f |
| PRODUCT NDC: | 49884-010 |
| APPLICATION NUMBER: | NDA020547 |
Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:
